HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation of calcium/calmodulin-dependent protein kinase II in obesity mediates suppression of hepatic insulin signaling.

Abstract
A hallmark of obesity is selective suppression of hepatic insulin signaling ("insulin resistance"), but critical gaps remain in our understanding of the molecular mechanisms. We now report a major role for hepatic CaMKII, a calcium-responsive kinase that is activated in obesity. Genetic targeting of hepatic CaMKII, its downstream mediator p38, or the p38 substrate and stabilizer MK2 enhances insulin-induced p-Akt in palmitate-treated hepatocytes and obese mouse liver, leading to metabolic improvement. The mechanism of improvement begins with induction of ATF6 and the ATF6 target p58(IPK), a chaperone that suppresses the PERK-p-eIF2α-ATF4 branch of the UPR. The result is a decrease in the ATF4 target TRB3, an inhibitor of insulin-induced p-Akt, leading to enhanced activation of Akt and its downstream metabolic mediators. These findings increase our understanding of the molecular mechanisms linking obesity to selective insulin resistance and suggest new therapeutic targets for type 2 diabetes and metabolic syndrome.
AuthorsLale Ozcan, Jane Cristina de Souza, Alp Avi Harari, Johannes Backs, Eric N Olson, Ira Tabas
JournalCell metabolism (Cell Metab) Vol. 18 Issue 6 Pg. 803-15 (Dec 03 2013) ISSN: 1932-7420 [Electronic] United States
PMID24268736 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Chemical References
  • Insulin
  • Intracellular Signaling Peptides and Proteins
  • Palmitates
  • MAP-kinase-activated kinase 2
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Camk2g protein, mouse
  • Mitogen-Activated Protein Kinase 14
Topics
  • Animals
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 (antagonists & inhibitors, genetics, metabolism)
  • Cells, Cultured
  • Endoplasmic Reticulum Stress (drug effects)
  • Hepatocytes (cytology, drug effects, metabolism)
  • Humans
  • Insulin (metabolism, pharmacology)
  • Intracellular Signaling Peptides and Proteins (genetics, metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Obese
  • Mice, Transgenic
  • Mitogen-Activated Protein Kinase 14 (antagonists & inhibitors, genetics, metabolism)
  • Obesity (metabolism, pathology)
  • Palmitates (pharmacology)
  • Phosphorylation (drug effects)
  • Protein Serine-Threonine Kinases (genetics, metabolism)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: